Overview

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects

Status:
Completed
Trial end date:
2019-02-15
Target enrollment:
Participant gender:
Summary
This study evaluates the safety, tolerability and pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Chinese heathy subjects. Part of the participants will receive Ammoxetine Hydrochloride Enteric-coated Tablets, while the other part will receive placebo.
Phase:
Phase 1
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.